ORKA

Oruka Therapeutics, Inc.

ORKA.US orukatx.com + Research + Basket
CIK 0000907654
Employees 68
Phone 650 606 7910
Fiscal year end December
IPO Aug 08, 1997
Address 855 Oak Grove Avenue, Menlo Park, CA, United States, 94025
101.41
+1.86 (+1.87%)
USD · NASDAQ
52-week range
25.23
115.52
Trading at 84% of the 52-week range
Market Cap
6.59B
P/E Ratio
0.00
Forward P/E
0.00
Book Value
18.20
Div. Yield
N/A
% Institutions
117.14%
% Insiders
1.26%

1 Year

+269.7%

3 Year

+754.0%

10 Year

-61.2%
Description

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Actions

Add an action for ORKA.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Lawrence Otto Klein Ph.D. President, CEO & Director 1983
Mr. Paul T. Quinlan General Counsel & Secretary 1963
Dr. Joana Goncalves M.D. Chief Medical Officer 1974
Mr. Arjun Agarwal CPA Senior VP of Finance & Treasurer 1976
Ms. Laura Sandler Chief Operating Officer 1977
Mr. Alan Lada VP of IR & Capital Markets NA
Mr. Christopher Finch Senior VP and Head of Business Development & Strategy NA
Dr. Rajiv Panwar Senior VP and Head of Chemistry, Manufacturing & Controls NA
Mr. Larry Todd Edwards Chief Commercial Officer 1963

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Apr 15, 2026 Joana Goncalves N/A Sale 7.00K $66.12 $462.84K SEC
Mar 16, 2026 Arjun Agarwal N/A Sale 395.00 $41.30 $16.31K SEC
Mar 16, 2026 Joana Goncalves N/A Sale 7.64K $40.91 $312.59K SEC
Mar 16, 2026 Lawrence Otto Klein N/A Sale 1.73K $41.30 $71.41K SEC
Feb 17, 2026 Joana Goncalves N/A Sale 7.00K $32.37 $226.59K SEC
Jan 15, 2026 Joana Goncalves N/A Sale 7.00K $31.81 $222.67K SEC
Dec 19, 2025 Joana Goncalves N/A Sale 7.00K $30.61 $214.27K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 9.06M Jun 30, 2026 13.68% $0.04 21.88%
BlackRock Inc 4.99M Jun 30, 2026 7.54% $0.01 41.48%
VR Adviser, LLC 4.15M Jun 30, 2026 6.27% $11.97 0.00%
Fairmount Funds Management LLC 3.71M Jun 30, 2026 5.60% $23.31 0.00%
Capital World Investors 3.40M Jun 30, 2026 5.14% $0.04 0.00%
RTW INVESTMENTS, LLC 3.14M Jun 30, 2026 4.74% $2.55 52.52%
State Street Corp 2.67M Jun 30, 2026 4.04% $0.01 65.67%
Vanguard Capital Management, LLC 2.36M Jun 30, 2026 3.57% $0.00 26.96%
Paradigm Biocapital Advisors LP 2.14M Jun 30, 2026 3.24% $3.82 -7.58%
Deep Track Capital, LP 1.93M Jun 30, 2026 2.91% $2.67 -5.32%
Bellevue Group AG 1.66M Jun 30, 2026 2.50% $3.32 226.86%
Franklin Templeton Inc 1.62M Jun 30, 2026 2.45% $0.03 61.49%
Remedium Capital Partners, LLC 1.57M Jun 30, 2026 2.36% $32.99 0.00%
RA Capital Management, LLC 1.55M Jun 30, 2026 2.35% $1.29 0.00%
Viking Global Investors LP 1.50M Jun 30, 2026 2.27% $0.41 -43.62%
Geode Capital Management, LLC 1.43M Jun 30, 2026 2.16% $0.01 49.75%
Jupiter Topco LLC 1.38M Jun 30, 2026 2.08% $0.05 0.00%
Perceptive Advisors LLC 1.35M Jun 30, 2026 2.03% $1.92 -3.61%
Polar Capital Holdings PLC 1.23M Jun 30, 2026 1.86% $0.28 17.27%
Citadel Advisors Llc 1.12M Jun 30, 2026 1.69% $0.01 11.06%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 1.90M 2.87% ▲ 9.95% Sep 30, 2026
2 State Street® SPDR® S&P® Biotech ETF 1.69M 2.55% ▼ 0.80% Oct 29, 2026
3 American Funds SMALLCAP World A 1.53M 2.31% ▲ 0.00% Sep 30, 2026
4 American Funds New Economy A 1.32M 2.00% ▲ 0.00% Sep 30, 2026
5 Fidelity Growth Company Fund 1.29M 1.95% ▲ 0.00% Aug 31, 2026
6 iShares Russell 2000 ETF 1.28M 1.93% ▼ 0.41% Oct 29, 2026
7 Polar Capital Biotech S Inc 1.16M 1.76% ▲ 0.00% Sep 30, 2026
8 Fidelity Select Health Care 880.00K 1.33% ▲ 1.73% Aug 31, 2026
9 Fidelity Advisor Biotechnology I 737.39K 1.11% ▲ 0.00% Aug 31, 2026
10 Fidelity Small Cap Growth 685.72K 1.04% ▲ 0.00% Jul 31, 2026

Financial Highlights

▼
Market Cap: $6.59B
EBITDA: $-154.94M
Book Value: $18.20
Earnings/Share: $-2.13
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -12.95%
ROE (TTM): -18.23%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $5.45B
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 66.21M
Shares Float: 56.89M
% Insiders: 1.26%
% Institutions: 117.14%
Shares Short: 6.11M
Shares Short (Prior Month): 7.78M
Short Ratio: 5.86
Short % Float: 13.44%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-83.00K
Gross Profit
subtotal
$-83.00K
SG&A
adjust
$-21.41M
R&D
adjust
$-100.64M
Operating Income
subtotal
$-122.05M
Other / Non-Operating Items
adjust
$16.62M
Net Income
subtotal
$-105.43M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ORKA.US!